69 |
LM PCI |
Chang-Wook Nam |
Dec. 12. 13 |
68 |
IVUS-MLA and FFR |
Seung-Jung Park |
Dec. 12. 13 |
67 |
Importance of the Coronary Microvasculature |
William F. Fearon |
Dec. 12. 13 |
66 |
Pd/Pa, iFR, Resting Gradients, and More: Why Can They Never Be as Good as Hyperemic Indices? |
Nico Pijls |
Dec. 12. 13 |
65 |
Coronary Angiography versus FFR: Why Mismatches |
Seung-Jung Park |
Dec. 12. 13 |
64 |
Randomized Trial to Compare Maximum Hyperemia After Single Bolus Injection of Regadenoson to Central Venous Adenosine Infusion |
Nico Pijls |
Dec. 12. 13 |
63 |
Pharmacologic Agents for Maximal Hyperemia |
Bon-Kwon Koo |
Dec. 12. 13 |
62 |
Experimental Basis and Clinical Validation of FFR |
Nico Pijls |
Dec. 12. 13 |
61 |
FFR in Acute Coronary Syndrome: Culprit and Non-culprit Lesion |
William F. Fearon |
Dec. 11. 13 |
60 |
Invited Case Presentation & Focus Review: FFR Guided PCI |
John McB. Hodgson |
May. 17. 12 |